2014 Q1 Form 10-K Financial Statement

#000114420414019382 Filed on March 31, 2014

View on sec.gov

Income Statement

Concept 2014 Q1 2013 Q4 2012 Q4
Revenue $1.062M $880.0K $600.0K
YoY Change 186.05% 46.67% 1400.0%
Cost Of Revenue $662.5K $840.0K $60.00K
YoY Change 161.34% 1300.0% 500.0%
Gross Profit $399.6K $40.00K $550.0K
YoY Change 239.19% -92.73% 2650.0%
Gross Profit Margin 37.62% 4.55% 91.67%
Selling, General & Admin $1.081M $1.010M $680.0K
YoY Change 76.22% 48.53% 36.0%
% of Gross Profit 270.38% 2525.0% 123.64%
Research & Development $236.8K $30.00K $680.0K
YoY Change -66.37% -95.59% 38.78%
% of Gross Profit 59.25% 75.0% 123.64%
Depreciation & Amortization $20.00K $10.00K $20.00K
YoY Change 100.0% -50.0% -300.0%
% of Gross Profit 5.0% 25.0% 3.64%
Operating Expenses $1.554M $1.040M $1.360M
YoY Change 0.89% -23.53% 37.37%
Operating Profit -$1.154M -$1.000M -$810.0K
YoY Change -18.85% 23.46% -16.49%
Interest Expense -$137.1K -$120.0K -$120.0K
YoY Change -33.68% 0.0% -47.83%
% of Operating Profit
Other Income/Expense, Net $179.1K
YoY Change -186.65%
Pretax Income -$975.1K -$1.130M -$930.0K
YoY Change -40.14% 21.51% -22.5%
Income Tax -$460.0K -$390.0K
% Of Pretax Income
Net Earnings -$975.1K -$670.0K -$540.0K
YoY Change -40.14% 24.07% -55.0%
Net Earnings / Revenue -91.8% -76.14% -90.0%
Basic Earnings Per Share
Diluted Earnings Per Share -$83.83K -$67.88K -$60.34K
COMMON SHARES
Basic Shares Outstanding 298.6M shares 245.1M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2014 Q1 2013 Q4 2012 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $11.20M $2.200M $1.700M
YoY Change 700.0% 29.41% 41.67%
Cash & Equivalents $6.416M $2.183M $1.729M
Short-Term Investments $4.700M
Other Short-Term Assets $200.0K $600.0K $500.0K
YoY Change 100.0% 20.0%
Inventory $146.5K $245.6K $682.4K
Prepaid Expenses
Receivables $300.0K $500.0K $100.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $11.83M $3.487M $2.940M
YoY Change 455.46% 18.62% 73.17%
LONG-TERM ASSETS
Property, Plant & Equipment $155.4K $144.4K $145.6K
YoY Change 11.19% -0.83% -6.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $409.7K $414.4K $254.2K
YoY Change 59.07% 63.0% -5.84%
Total Long-Term Assets $565.1K $558.8K $399.8K
YoY Change 42.23% 39.75% -5.94%
TOTAL ASSETS
Total Short-Term Assets $11.83M $3.487M $2.940M
Total Long-Term Assets $565.1K $558.8K $399.8K
Total Assets $12.39M $4.046M $3.339M
YoY Change 390.48% 21.15% 57.33%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $527.6K $786.5K $800.7K
YoY Change -25.13% -1.77% 18.59%
Accrued Expenses $400.0K $400.0K $300.0K
YoY Change 33.33% 33.33% -50.0%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $1.700M $1.600M $900.0K
YoY Change 77.78% 200.0%
Total Short-Term Liabilities $3.299M $3.065M $2.077M
YoY Change 232.05% 47.58% 35.92%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change -100.0%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $3.299M $3.065M $2.077M
Total Long-Term Liabilities $0.00 $0.00
Total Liabilities $3.300M $3.065M $2.077M
YoY Change 232.18% 47.58% 15.11%
SHAREHOLDERS EQUITY
Retained Earnings -$105.8M
YoY Change
Common Stock $299.0K $10.05K $215.0K
YoY Change 30.61% -95.32% 21.02%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$7.259M -$14.27M -$11.63M
YoY Change
Total Liabilities & Shareholders Equity $12.39M $4.046M $3.339M
YoY Change 390.48% 21.15% 57.33%

Cashflow Statement

Concept 2014 Q1 2013 Q4 2012 Q4
OPERATING ACTIVITIES
Net Income -$975.1K -$670.0K -$540.0K
YoY Change -40.14% 24.07% -55.0%
Depreciation, Depletion And Amortization $20.00K $10.00K $20.00K
YoY Change 100.0% -50.0% -300.0%
Cash From Operating Activities -$800.1K -$1.100M -$770.0K
YoY Change -1.16% 42.86% -30.63%
INVESTING ACTIVITIES
Capital Expenditures $21.37K -$170.0K -$20.00K
YoY Change 877.58% 750.0%
Acquisitions
YoY Change
Other Investing Activities -$4.750M $0.00
YoY Change
Cash From Investing Activities -$4.771M -$170.0K -$20.00K
YoY Change 218148.44% 750.0%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $9.451M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $9.803M 1.180M 460.0K
YoY Change 2078.49% 156.52%
NET CHANGE
Cash From Operating Activities -$800.1K -1.100M -770.0K
Cash From Investing Activities -$4.771M -170.0K -20.00K
Cash From Financing Activities $9.803M 1.180M 460.0K
Net Change In Cash $4.232M -90.00K -330.0K
YoY Change -1270.26% -72.73% -70.27%
FREE CASH FLOW
Cash From Operating Activities -$800.1K -$1.100M -$770.0K
Capital Expenditures $21.37K -$170.0K -$20.00K
Free Cash Flow -$821.5K -$930.0K -$750.0K
YoY Change 1.21% 24.0% -32.43%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013 ctso Abandoned Patents
AbandonedPatents
USD
CY2012 ctso Abandoned Patents
AbandonedPatents
USD
ctso Abandoned Patents
AbandonedPatents
183556 USD
CY2013Q4 ctso Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
361700 USD
CY2012Q4 ctso Accrued Expenses And Other Current Liabilities
AccruedExpensesAndOtherCurrentLiabilities
349841 USD
CY2005 ctso Adjustments To Additional Paid In Capital Equity Investments Transactions
AdjustmentsToAdditionalPaidInCapitalEquityInvestmentsTransactions
USD
CY2009 ctso Adjustments To Additional Paid In Capital Warrants Modified
AdjustmentsToAdditionalPaidInCapitalWarrantsModified
14885 USD
CY2000 ctso Capital Contributions
CapitalContributions
1382872 USD
CY2001 ctso Capital Contributions
CapitalContributions
13411506 USD
CY2002 ctso Capital Contributions
CapitalContributions
6739189 USD
CY2003 ctso Capital Contributions
CapitalContributions
4067250 USD
CY2006 ctso Adjustment To Additional Paid In Capital Merger Transaction
AdjustmentToAdditionalPaidInCapitalMergerTransaction
10000000 USD
CY1999 ctso Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
1070740 USD
CY2000 ctso Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
88363 USD
CY2001 ctso Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
161073 USD
CY2002 ctso Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
156073 USD
CY2003 ctso Adjustment To Common Stock Issued
AdjustmentToCommonStockIssued
16624 USD
CY2013Q4 ctso Aggregate Debt Or Equity Financing Amount
AggregateDebtOrEquityFinancingAmount
750000 USD
CY2013Q4 ctso Agreement To Purchase Shares Value
AgreementToPurchaseSharesValue
8500000 USD
CY2013 ctso Agreement To Purchase Shares Value During Period
AgreementToPurchaseSharesValueDuringPeriod
50000 USD
CY1999 ctso Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
46772 USD
CY2000 ctso Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
15667 USD
CY2001 ctso Amortization Of Deferred Stock Based Compensation
AmortizationOfDeferredStockBasedCompensation
12499 USD
ctso Capital Contributions
CapitalContributions
1143487 USD
CY1998 ctso Capital Contributions
CapitalContributions
2518236 USD
CY1999 ctso Capital Contributions
CapitalContributions
14407916 USD
CY2004 ctso Capital Contributions
CapitalContributions
512555 USD
CY2005 ctso Capital Contributions
CapitalContributions
92287 USD
CY2013 ctso Change In Fair Value Of Management Units
ChangeInFairValueOfManagementUnits
USD
CY2012 ctso Change In Fair Value Of Management Units
ChangeInFairValueOfManagementUnits
USD
ctso Change In Fair Value Of Management Units
ChangeInFairValueOfManagementUnits
278087 USD
CY2003 ctso Changes In Fair Value Of Noncontrolling Interests
ChangesInFairValueOfNoncontrollingInterests
2952474 USD
CY2004 ctso Changes In Fair Value Of Noncontrolling Interests
ChangesInFairValueOfNoncontrollingInterests
-2396291 USD
CY2005 ctso Changes In Fair Value Of Noncontrolling Interests
ChangesInFairValueOfNoncontrollingInterests
-14551 USD
CY2013 ctso Common Stock Issued As Inducement To Convert Convertible Notes Payable And Accrued Interest
CommonStockIssuedAsInducementToConvertConvertibleNotesPayableAndAccruedInterest
USD
CY2012 ctso Common Stock Issued As Inducement To Convert Convertible Notes Payable And Accrued Interest
CommonStockIssuedAsInducementToConvertConvertibleNotesPayableAndAccruedInterest
USD
ctso Common Stock Issued As Inducement To Convert Convertible Notes Payable And Accrued Interest
CommonStockIssuedAsInducementToConvertConvertibleNotesPayableAndAccruedInterest
3351961 USD
ctso Common Stock Issued Value Subscriptions
CommonStockIssuedValueSubscriptions
440000 USD
CY1998 ctso Common Stock Issued Value Subscriptions
CommonStockIssuedValueSubscriptions
50000 USD
CY2000 ctso Common Stock Issued Value Subscriptions
CommonStockIssuedValueSubscriptions
100000 USD
CY1998 ctso Common Stock Options Granted Value
CommonStockOptionsGrantedValue
1671 USD
CY2002 ctso Common Stock Options Granted Value
CommonStockOptionsGrantedValue
176250 USD
CY2003 ctso Common Stock Options Granted Value
CommonStockOptionsGrantedValue
65681 USD
CY2001 ctso Common Stock Options Granted Value Employee
CommonStockOptionsGrantedValueEmployee
2847 USD
CY2002 ctso Common Stock Options Granted Value Employee
CommonStockOptionsGrantedValueEmployee
2847 USD
CY2013 ctso Consulting Fees
ConsultingFees
USD
CY2012 ctso Consulting Fees
ConsultingFees
USD
ctso Consulting Fees
ConsultingFees
237836 USD
CY2013Q4 ctso Convertible Notes Current Unamortized Discount
ConvertibleNotesCurrentUnamortizedDiscount
198644 USD
CY2012Q4 ctso Convertible Notes Current Unamortized Discount
ConvertibleNotesCurrentUnamortizedDiscount
178775 USD
CY2013Q2 ctso Debt Instrument Percent Of Principal Amount
DebtInstrumentPercentOfPrincipalAmount
0.5 pure
CY2013 ctso Debt Discount
DebtDiscount
331117 USD
CY2012 ctso Debt Discount
DebtDiscount
87400 USD
ctso Debt Discount
DebtDiscount
1975322 USD
ctso Debt Instrument Maturity Period
DebtInstrumentMaturityPeriod
P1Y
CY2013Q2 ctso Debt Instrument Maturity Period
DebtInstrumentMaturityPeriod
P1Y
CY2013Q3 ctso Debt Instrument Percent Of Principal Amount
DebtInstrumentPercentOfPrincipalAmount
0.5 pure
CY1999 ctso Deferred Compensation Obligation
DeferredCompensationObligation
USD
CY2000 ctso Deferred Compensation Obligation
DeferredCompensationObligation
USD
CY2013 ctso Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
-2378919 USD
CY2009 ctso Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
-586023 USD
CY2010 ctso Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
-2008882 USD
CY2011 ctso Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
-3015023 USD
CY2013 ctso Issuance Of Common Stock In Exchange For Convertible Notes Shares
IssuanceOfCommonStockInExchangeForConvertibleNotesShares
1634615 shares
CY2013 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
1226042 USD
CY2012 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
798911 USD
CY2012 ctso Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
-2493930 USD
CY2008 ctso Dividends Preferred Stock Series B
DividendsPreferredStockSeriesB
-262717 USD
CY2002 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
-1350828 USD
CY2003 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
-281340 USD
CY2005 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
51565 USD
CY2006 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
113821100 USD
CY2011 ctso Issuance Of Common Stock In Exchange For Convertible Notes Value
IssuanceOfCommonStockInExchangeForConvertibleNotesValue
1515130 USD
CY2007 ctso Issuance Of Common Stock Value Dividends And Interest
IssuanceOfCommonStockValueDividendsAndInterest
361496 USD
CY2005 ctso Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
836319 USD
CY2006 ctso Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
5878140 USD
CY2007 ctso Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
23002 USD
CY2011 ctso Issuance Of Common Stock Value In Settlement Of Accounts Payable
IssuanceOfCommonStockValueInSettlementOfAccountsPayable
5000 USD
CY2013 ctso Management Units Issued
ManagementUnitsIssued
USD
CY2012 ctso Management Units Issued
ManagementUnitsIssued
USD
ctso Management Units Issued
ManagementUnitsIssued
437206 USD
CY2013 ctso Member Units Issued
MemberUnitsIssued
USD
CY2012 ctso Member Units Issued
MemberUnitsIssued
USD
CY2013Q4 ctso Number Of Patents Issued
NumberOfPatentsIssued
32 pure
CY2013 ctso Period In Which Certain Amount Of Stock Can Be Sold
PeriodInWhichCertainAmountOfStockCanBeSold
P2Y
CY2013 ctso Period In Which Common Stock Can Be Sold
PeriodInWhichCommonStockCanBeSold
P32M
CY2013 ctso Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
2395520 USD
CY2012 ctso Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
2511412 USD
ctso Preferred Dividends Accrued Not Yet Paid
PreferredDividendsAccruedNotYetPaid
13317555 USD
CY2013 ctso Preferred Stock Additional Shares Available For Issuance
PreferredStockAdditionalSharesAvailableForIssuance
87800000 shares
CY2013Q4 ctso Preferred Stock Value Not Included In Stockholders Equity
PreferredStockValueNotIncludedInStockholdersEquity
15246350 USD
CY2012Q4 ctso Preferred Stock Value Not Included In Stockholders Equity
PreferredStockValueNotIncludedInStockholdersEquity
12887817 USD
CY2013 ctso Proceeds From Sale Of Net Operating Loss Carryforwards
ProceedsFromSaleOfNetOperatingLossCarryforwards
458000 USD
CY2012Q4 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsWeightedAverageGrantDateFairValue
0.050
CY2013 ctso Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
2235000 shares
CY2012 ctso Share Based Compensation Arrangement By Share Based Payment Award Options Cancelled In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsCancelledInPeriod
4640000 shares
CY2013Q4 ctso Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding And Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingAndExercisableAggregateIntrinsicValue
1194000 USD
CY2012 ctso Proceeds From Sale Of Net Operating Loss Carryforwards
ProceedsFromSaleOfNetOperatingLossCarryforwards
392000 USD
CY2013 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Forfeited In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsForfeitedInPeriodWeightedAverageGrantDateFairValue
0.056
CY2013 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsForfeituresInPeriod
2035000 shares
CY2013Q4 ctso Share Based Compensation Arrangement By Sharebased Payment Award Nonvested Options Grant Date Fair Value
ShareBasedCompensationArrangementBySharebasedPaymentAwardNonvestedOptionsGrantDateFairValue
263650 USD
CY2013 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Granted In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantedInPeriodWeightedAverageGrantDateFairValue
0.035
CY2013 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsGrantsInPeriod
14076000 shares
CY2013Q4 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingNumber
13418000 shares
CY2012Q4 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsOutstandingNumber
7394000 shares
CY2013 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsVestedInPeriod
6017000 shares
CY2013 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.048
CY2013 ctso Share Based Compensation Arrangement By Share Based Payment Award Non Vested Options Vested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonVestedOptionsVestedNumber
9544000 shares
CY2013Q4 ctso Share Based Compensation Arrangement By Share Based Payment Award Nonvested Options Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonvestedOptionsWeightedAverageGrantDateFairValue
0.034
CY2013 ctso Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Granted In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantedInPeriodWeightedAverageRemainingContractualTerm
P5Y6M
CY2012 ctso Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Granted In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingGrantedInPeriodWeightedAverageRemainingContractualTerm
P6Y10M24D
CY2013Q4 ctso Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y1M6D
CY2012Q4 ctso Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y1M6D
CY2011Q4 ctso Share Based Compensation Arrangements By Share Based Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y2M12D
CY1999 ctso Stock Issued During Period Stock And Warrants For Services Or Claims
StockIssuedDuringPeriodStockAndWarrantsForServicesOrClaims
468526 USD
CY2009 ctso Stock Issued During Period Value Conversion Of Convertible Securities Preferred Stock
StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesPreferredStock
-6704 USD
CY2006 ctso Stock Issued During Period Value Merger
StockIssuedDuringPeriodValueMerger
USD
CY2006 ctso Stock Issued During Period Value Merger Note Payable
StockIssuedDuringPeriodValueMergerNotePayable
10000000 USD
CY2008 ctso Stock Issued During Period Value New Issues Preferred Stock
StockIssuedDuringPeriodValueNewIssuesPreferredStock
-364747 USD
CY2006 ctso Stock Issued During Period Value New Issues Preferred Stock
StockIssuedDuringPeriodValueNewIssuesPreferredStock
53000000 USD
CY2013 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2013 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2013 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2013
CY2006 ctso Stock Issued During Period Value Redemption Of Convertible Securities
StockIssuedDuringPeriodValueRedemptionOfConvertibleSecurities
10000000 USD
CY2013 ctso Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
139526 USD
CY2012 ctso Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
USD
CY2009 ctso Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
USD
CY2011 ctso Stock Issued During Period Value Stock Warrants Exercised
StockIssuedDuringPeriodValueStockWarrantsExercised
USD
CY2013 ctso Supplemental Noncash Transactions
SupplementalNoncashTransactions
USD
CY2012 ctso Supplemental Noncash Transactions
SupplementalNoncashTransactions
USD
ctso Supplemental Noncash Transactions
SupplementalNoncashTransactions
768063 USD
CY2013 ctso Technology And Content Expense
TechnologyAndContentExpense
USD
CY2012 ctso Technology And Content Expense
TechnologyAndContentExpense
USD
ctso Technology And Content Expense
TechnologyAndContentExpense
4550000 USD
ctso Technology Contributions
TechnologyContributions
4550000 USD
ctso Warrant Exercise Price
WarrantExercisePrice
0.10
CY2013Q2 ctso Warrant Exercise Price
WarrantExercisePrice
0.15
CY2013 dei Amendment Flag
AmendmentFlag
false
CY2013 dei Document Period End Date
DocumentPeriodEndDate
2013-12-31
CY2013 dei Document Type
DocumentType
10-K
CY2013 dei Entity Central Index Key
EntityCentralIndexKey
0001175151
CY2014Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
298568099 shares
CY2013 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2013 dei Entity Filer Category
EntityFilerCategory
Smaller Reporting Company
CY2013Q2 dei Entity Public Float
EntityPublicFloat
27665000 USD
CY2013 dei Entity Registrant Name
EntityRegistrantName
Cytosorbents Corp
CY2013 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2013 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2013 dei Trading Symbol
TradingSymbol
ctso
CY2013Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1148217 USD
CY2012Q4 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
1150511 USD
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
786517 USD
CY2012Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
800670 USD
CY2013Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
351435 USD
CY2012Q4 us-gaap Accounts Payable Other Current And Noncurrent
AccountsPayableOtherCurrentAndNoncurrent
364285 USD
CY2013Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
453017 USD
CY2012Q4 us-gaap Accounts Receivable Net
AccountsReceivableNet
51779 USD
CY2013Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
364599 USD
CY2012Q4 us-gaap Accrued Professional Fees Current And Noncurrent
AccruedProfessionalFeesCurrentAndNoncurrent
177797 USD
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2401354 USD
CY2012Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2369240 USD
CY2013Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-55987 USD
CY2012Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-12662 USD
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
91343135 USD
CY2012Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
86903415 USD
CY2013 us-gaap Adjustment For Amortization
AdjustmentForAmortization
24459 USD
CY2012 us-gaap Adjustment For Amortization
AdjustmentForAmortization
25289 USD
us-gaap Adjustment For Amortization
AdjustmentForAmortization
132150 USD
CY2013 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
USD
CY2012 us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
USD
us-gaap Adjustment Of Warrants Granted For Services
AdjustmentOfWarrantsGrantedForServices
533648 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
331117 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
87700 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
306805 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Convertible Debt With Conversion Feature
AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature
1250000 USD
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
456937 USD
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
63127 USD
CY2006 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
1433520 USD
CY2007 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
498955 USD
CY2008 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
363563 USD
CY2009 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
236705 USD
CY2010 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
149325 USD
CY2011 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
865535 USD
CY2006 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
-6205630 USD
CY2008 us-gaap Adjustments To Additional Paid In Capital Warrant Issued
AdjustmentsToAdditionalPaidInCapitalWarrantIssued
40354 USD
CY2013 us-gaap Advertising Expense
AdvertisingExpense
269000 USD
CY2012 us-gaap Advertising Expense
AdvertisingExpense
23000 USD
CY2013 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
456900 USD
CY2012 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
63100 USD
CY2013Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1729344 USD
CY2012Q4 us-gaap Allowance For Doubtful Accounts Receivable
AllowanceForDoubtfulAccountsReceivable
0 USD
CY2013 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
311248 USD
CY2012 us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
471352 USD
us-gaap Amortization Of Debt Discount Premium
AmortizationOfDebtDiscountPremium
2776977 USD
CY2013Q4 us-gaap Assets
Assets
4045735 USD
CY2012Q4 us-gaap Assets
Assets
3339408 USD
CY2013Q4 us-gaap Assets Current
AssetsCurrent
3486967 USD
CY2012Q4 us-gaap Assets Current
AssetsCurrent
2939588 USD
CY2013Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
558768 USD
CY2012Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
399820 USD
CY2013 us-gaap Basis Of Accounting
BasisOfAccounting
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> <strong>1. BASIS OF PRESENTATION</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> &nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The accompanying consolidated financial statements include the results of CytoSorbents Corporation (the "Parent"), CytoSorbents, Inc. its wholly-owned operating subsidiary (the "Subsidiary"), and CytoSorbents Europe GmbH, its wholly-owned European subsidiary (the "European Subsidiary"), collectively referred to as "the Company."</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> &nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The accompanying consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and satisfaction of liabilities in the normal course of business. The Company has experienced negative cash flows from operations since inception and has a deficit accumulated during the development stage at December 31, 2013 of $105,805,775. The Company is not currently generating significant revenue and is dependent on the proceeds of present and future financings to fund its research, development and commercialization program. The Company believes that it currently has adequate funding for more than the next twelve months of operations, however, it may have to raise additional capital to fund future operations. Although the Company has historically been successful in raising additional capital through equity and debt financings, there can be no assurance that the Company will be successful in raising additional capital in the future or that it will be on favorable terms. Furthermore, if the Company is successful in raising the additional financing, there can be no assurance that the amount will be sufficient to complete the Company&#39;s plans. These matters raise substantial doubt about the Company&#39;s ability to continue as a going concern. These consolidated financial statements do not include any adjustments related to the outcome of this uncertainty.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> &nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The Company is a development stage company and has not yet generated significant revenues. Since inception, the Company&#39;s expenses relate primarily to research and development, organizational activities, clinical manufacturing, regulatory compliance and operational strategic planning. Although the Company has made advances on these matters, there can be no assurance that the Company will continue to be successful regarding these issues, nor can there be any assurance that the Company will successfully implement its long-term strategic plans.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in"> &nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px"> The Company has developed an intellectual property portfolio, including 32 issued U.S. patents and multiple pending patents, covering materials, methods of production, systems incorporating the technology and multiple medical uses.</p> <!--EndFragment--></div> </div>
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2183030 USD
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1186653 USD
CY1997Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
USD
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
453686 USD
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
542691 USD
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
2183030 USD
CY2013Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
26437617 shares
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2012Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2012Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
800000000 shares
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
251319547 shares
CY2012Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
214967503 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
251319547 shares
CY2012Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
214967503 shares
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
251320 USD
CY2013 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
USD
CY2012 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
USD
us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
399395 USD
CY2013Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
1644000 USD
CY2012Q4 us-gaap Common Stock Value
CommonStockValue
214968 USD
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4721120 USD
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-3676168 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-92544207 USD
CY2013 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> <strong>Concentration of Credit Risk</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in; font-size-adjust: none; font-stretch: normal"> &nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> The Company maintains cash balances, at times, with financial institutions in excess of amounts insured by the Federal Deposit Insurance Corporation. Management monitors the soundness of these institutions in an effort to minimize its collection risk of these balances.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> &nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> As of December 31, 2013, a U.S. Government agency accounted for approximately 66 percent of outstanding accounts receivable. At December 31, 2012, grant and accounts receivable consisted of direct hospital customers who in the aggregate represented 100% of outstanding accounts receivable, each of whom individually had more than 10 percent of outstanding accounts receivable. For the year ended December 31, 2013, approximately 62 percent of revenues were from two U.S. government agencies, and no other agency, distributor, or direct customer represented more than 10% of the Company&#39;s revenue. For the year ended December 31, 2012, approximately 81 percent of revenue was from a U.S. government grant agency.</p> <!--EndFragment--></div> </div>
CY2013 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
USD
CY2012 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
USD
us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
559 USD
CY2012Q4 us-gaap Convertible Notes Payable
ConvertibleNotesPayable
926000 USD
CY2013Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1644356 USD
CY2012Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
926225 USD
CY2013 us-gaap Cost Of Goods Sold
CostOfGoodsSold
1911565 USD
CY2012 us-gaap Cost Of Goods Sold
CostOfGoodsSold
319298 USD
us-gaap Cost Of Goods Sold
CostOfGoodsSold
2745436 USD
CY2013 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
1226042 USD
CY2012 us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
USD
us-gaap Debt Conversion Converted Instrument Amount1
DebtConversionConvertedInstrumentAmount1
13175491 USD
CY2012 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
9739912 shares
CY2013Q2 us-gaap Debt Conversion Converted Instrument Shares Issued1
DebtConversionConvertedInstrumentSharesIssued1
8784000 shares
CY2013 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
160105 USD
CY2012 us-gaap Debt Instrument Convertible Beneficial Conversion Feature
DebtInstrumentConvertibleBeneficialConversionFeature
48912 USD
CY2013Q3 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.125
CY2013 us-gaap Depreciation
Depreciation
39891 USD
CY2012 us-gaap Depreciation
Depreciation
29316 USD
us-gaap Depreciation
Depreciation
2460678 USD
CY2013 us-gaap Depreciation And Amortization
DepreciationAndAmortization
64350 USD
CY2012 us-gaap Depreciation And Amortization
DepreciationAndAmortization
54606 USD
CY2013Q2 us-gaap Debt Instrument Convertible Conversion Price1
DebtInstrumentConvertibleConversionPrice1
0.125
CY2013Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1511883 USD
CY2012Q4 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
612300 USD
CY2013Q3 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
745000 USD
CY2013Q2 us-gaap Debt Instrument Face Amount
DebtInstrumentFaceAmount
1098000 USD
us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.08 pure
CY2013Q2 us-gaap Debt Instrument Interest Rate During Period
DebtInstrumentInterestRateDuringPeriod
0.08 pure
CY2013Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
199000 USD
CY2012Q4 us-gaap Debt Instrument Unamortized Discount
DebtInstrumentUnamortizedDiscount
179000 USD
CY2013Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
272359 USD
CY2012Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
USD
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2568371 USD
CY2013Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
105805775 USD
CY2012Q4 us-gaap Development Stage Enterprise Deficit Accumulated During Development Stage
DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage
98732460 USD
CY2013 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2012 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2006 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2008 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2009 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2010 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2011 us-gaap Dividends Preferred Stock Stock
DividendsPreferredStockStock
USD
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.03
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
25000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
25000 USD
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2012 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
-0.34 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.298 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
0.288 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
0.004 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Equity In Earnings Losses Of Unconsolidated Subsidiary
EffectiveIncomeTaxRateReconciliationEquityInEarningsLossesOfUnconsolidatedSubsidiary
0.008 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.029 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Nondeductible Expense
EffectiveIncomeTaxRateReconciliationNondeductibleExpense
0.044 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.009 pure
CY2012 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
pure
CY2013 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-43325 USD
CY2012 us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-12662 USD
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-55987 USD
CY2013Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
86000 USD
CY2013 us-gaap Equity Issuance Per Share Amount
EquityIssuancePerShareAmount
0.10
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
25000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
25000 USD
CY2013Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
25000 USD
CY2013 us-gaap Freight Costs
FreightCosts
33000 USD
CY2012 us-gaap Freight Costs
FreightCosts
65000 USD
CY2013 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
CY2012 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
USD
us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
21663 USD
CY2013 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
CY2012 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
216617 USD
CY2013 us-gaap Gross Profit
GrossProfit
511102 USD
CY2012 us-gaap Gross Profit
GrossProfit
1023638 USD
us-gaap Gross Profit
GrossProfit
2056690 USD
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
432365 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
876860 USD
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-458279 USD
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-391756 USD
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1397353 USD
CY2013Q4 us-gaap Inventory Net
InventoryNet
245608 USD
CY2012Q4 us-gaap Inventory Net
InventoryNet
682372 USD
CY2013 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-5136074 USD
CY2012 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-4055262 USD
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-93885573 USD
CY2013 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
118748 USD
CY2012 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
147948 USD
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
3224552 USD
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
401238 USD
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
15701 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
453017 USD
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
272359 USD
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
USD
us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
272359 USD
CY2013 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
USD
CY2012 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
USD
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
1823103 USD
CY2013 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-436764 USD
CY2012 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
251350 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
245608 USD
CY2013 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
6942 USD
CY2012 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-9441 USD
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
53895 USD
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
129219 USD
CY2012 us-gaap Interest Expense Debt
InterestExpenseDebt
235762 USD
CY2013 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-422843 USD
CY2012 us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-564428 USD
us-gaap Interest Income Expense Nonoperating Net
InterestIncomeExpenseNonoperatingNet
-7724393 USD
CY2013 us-gaap Interest Paid
InterestPaid
USD
CY2012 us-gaap Interest Paid
InterestPaid
USD
us-gaap Interest Paid
InterestPaid
590189 USD
CY2013Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
107098 USD
CY2012Q4 us-gaap Inventory Finished Goods
InventoryFinishedGoods
438790 USD
CY2013Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
37982 USD
CY2012Q4 us-gaap Inventory Raw Materials
InventoryRawMaterials
48702 USD
CY2013Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
100528 USD
CY2012Q4 us-gaap Inventory Work In Process
InventoryWorkInProcess
194880 USD
CY2013 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
65468 USD
CY2012 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
95468 USD
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
315000 USD
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
334000 USD
CY2013Q4 us-gaap Liabilities
Liabilities
3064932 USD
CY2012Q4 us-gaap Liabilities
Liabilities
2076736 USD
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4045735 USD
CY2012Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
3339408 USD
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3064932 USD
CY2012Q4 us-gaap Liabilities Current
LiabilitiesCurrent
2076736 USD
CY2013 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4202687 USD
CY2012 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4210606 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
76657550 USD
CY2013 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-216356 USD
CY2012 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-38806 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-4735357 USD
CY2013 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3489320 USD
CY2012 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3616447 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-69683176 USD
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-4677795 USD
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-3663506 USD
us-gaap Net Income Loss
NetIncomeLoss
-92488220 USD
us-gaap Net Income Loss
NetIncomeLoss
-5256012 USD
CY1998 us-gaap Net Income Loss
NetIncomeLoss
-1867348 USD
CY1999 us-gaap Net Income Loss
NetIncomeLoss
-10753871 USD
CY2000 us-gaap Net Income Loss
NetIncomeLoss
-3066388 USD
CY2001 us-gaap Net Income Loss
NetIncomeLoss
-15392618 USD
CY2002 us-gaap Net Income Loss
NetIncomeLoss
-11871668 USD
CY2003 us-gaap Net Income Loss
NetIncomeLoss
-6009283 USD
CY2004 us-gaap Net Income Loss
NetIncomeLoss
-1096683 USD
CY2005 us-gaap Net Income Loss
NetIncomeLoss
-3665596 USD
CY2006 us-gaap Net Income Loss
NetIncomeLoss
-76715800 USD
CY2007 us-gaap Net Income Loss
NetIncomeLoss
-3350754 USD
CY2008 us-gaap Net Income Loss
NetIncomeLoss
-3017890 USD
CY2009 us-gaap Net Income Loss
NetIncomeLoss
-2736715 USD
CY2010 us-gaap Net Income Loss
NetIncomeLoss
-2908865 USD
CY2011 us-gaap Net Income Loss
NetIncomeLoss
-5481648 USD
CY2013 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-7073315 USD
CY2012 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6174918 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-105805775 USD
CY2013 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-422843 USD
CY2012 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-564428 USD
us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7847608 USD
CY2013 us-gaap Operating Expenses
OperatingExpenses
5224333 USD
CY2012 us-gaap Operating Expenses
OperatingExpenses
4514472 USD
us-gaap Operating Expenses
OperatingExpenses
88094655 USD
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-4713231 USD
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-3490834 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-86037965 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
178135 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
145735 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Rolling Year Three
OperatingLeasesFutureMinimumPaymentsDueInRollingYearThree
16200 USD
CY2013Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
16200 USD
CY2013Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
432183 USD
CY2012Q4 us-gaap Other Accrued Liabilities Current And Noncurrent
OtherAccruedLiabilitiesCurrentAndNoncurrent
608429 USD
CY2013 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
USD
CY2012 us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
USD
us-gaap Other Amortization Of Deferred Charges
OtherAmortizationOfDeferredCharges
74938 USD
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
414375 USD
CY2012Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
254220 USD
CY2013 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-43325 USD
CY2012 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-12662 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-55987 USD
CY2013 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-43325 USD
CY2012 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-12662 USD
CY2013 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-3300000 USD
CY2012 us-gaap Other Comprehensive Income Loss Tax
OtherComprehensiveIncomeLossTax
-3100000 USD
CY2013Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
360481 USD
CY2012Q4 us-gaap Other Intangible Assets Net
OtherIntangibleAssetsNet
207267 USD
CY2013 us-gaap Other Noncash Expense
OtherNoncashExpense
USD
CY2012 us-gaap Other Noncash Expense
OtherNoncashExpense
USD
us-gaap Other Noncash Expense
OtherNoncashExpense
361496 USD
CY2013 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
USD
CY2012 us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
USD
us-gaap Other Nonoperating Expense
OtherNonoperatingExpense
361495 USD
CY2013 us-gaap Other Operating Income
OtherOperatingIncome
USD
CY2012 us-gaap Other Operating Income
OtherOperatingIncome
USD
us-gaap Other Operating Income
OtherOperatingIncome
6055483 USD
CY2013 us-gaap Paid In Kind Interest
PaidInKindInterest
USD
CY2012 us-gaap Paid In Kind Interest
PaidInKindInterest
USD
us-gaap Paid In Kind Interest
PaidInKindInterest
3147 USD
CY2013 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
177672 USD
CY2012 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
18956 USD
us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
676186 USD
CY2013 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
USD
CY2012 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
USD
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
393607 USD
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
499395 USD
CY2013 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
USD
CY2012 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
USD
us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
393607 USD
CY2013 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.03
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.04
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
47923642 shares
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
36667616 shares
CY2013 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
USD
CY2012 us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
USD
us-gaap Payments To Acquire Loans Receivable
PaymentsToAcquireLoansReceivable
1632168 USD
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38684 USD
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19850 USD
us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
2459494 USD
CY2013Q4 us-gaap Preferred Stock Capital Shares Reserved For Future Issuance
PreferredStockCapitalSharesReservedForFutureIssuance
15600000 shares
CY2013 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2395520 USD
CY2012 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
2511412 USD
us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
13317555 USD
CY2013Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1
CY2013Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Preferred Stock Value
PreferredStockValue
1760 USD
CY2012Q4 us-gaap Preferred Stock Value
PreferredStockValue
1594 USD
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
605312 USD
CY2012Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
476093 USD
CY2013 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
2199967 USD
CY2012 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
3500001 USD
us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
52671768 USD
CY2013 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
USD
CY2012 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
USD
us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
9579040 USD
CY2013 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
1843000 USD
CY2012 us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
700000 USD
us-gaap Proceeds From Other Debt
ProceedsFromOtherDebt
13731881 USD
CY2013 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
USD
CY2012 us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
USD
CY2012 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
USD
us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
32491 USD
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
20194 USD
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
10605 USD
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
35940 USD
CY2013 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
139526 USD
CY2012 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
139526 USD
CY2013 us-gaap Professional Fees
ProfessionalFees
908644 USD
CY2012 us-gaap Professional Fees
ProfessionalFees
627245 USD
us-gaap Professional Fees
ProfessionalFees
9493779 USD
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.11
CY2008 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
0 USD
CY2009 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
681558 USD
CY2010 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
1437814 USD
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2545747 USD
CY2012Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2514840 USD
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
144393 USD
CY2012Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
145600 USD
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.15
CY2011 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
187462 USD
CY2013 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
65468 USD
CY2013 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2299967 USD
CY2012 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
3660153 USD
CY2006 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
7998850 USD
CY2013 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
USD
CY2012 us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
255882 USD
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1738938 USD
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
2532489 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
55668397 USD
CY2013 us-gaap Revenue From Grants
RevenueFromGrants
1600880 USD
CY2012 us-gaap Revenue From Grants
RevenueFromGrants
1191362 USD
us-gaap Revenue From Grants
RevenueFromGrants
3792687 USD
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
39833438 shares
CY2013 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
821787 USD
CY2012 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
151574 USD
us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1009439 USD
CY2013 us-gaap Sales Revenue Net
SalesRevenueNet
2422667 USD
CY2012 us-gaap Sales Revenue Net
SalesRevenueNet
1342936 USD
us-gaap Sales Revenue Net
SalesRevenueNet
4802126 USD
us-gaap Stock Issued1
StockIssued1
633133 USD
CY2013 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
556737 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.20
CY2012Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.23
CY2011Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.39
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.04
CY2012 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
303039 shares
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
20386 USD
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
14484 USD
CY2006 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
USD
CY2013Q4 us-gaap Security Deposit
SecurityDeposit
53894 USD
CY2012Q4 us-gaap Security Deposit
SecurityDeposit
46953 USD
CY2013 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
2576751 USD
CY2012 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1354738 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
28987962 USD
CY2013 us-gaap Service Management Costs
ServiceManagementCosts
USD
CY2012 us-gaap Service Management Costs
ServiceManagementCosts
USD
us-gaap Service Management Costs
ServiceManagementCosts
1334285 USD
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.28 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0189 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0075 pure
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
34505642 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
28237 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
190783 shares
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
14076000 shares
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1968000 shares
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.04
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
7.71
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
34.72
CY2013 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.12
CY2012 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.14
CY2007 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
USD
CY2010 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
749999 USD
CY2011 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2643766 USD
CY2013 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-100000 USD
CY2010 us-gaap Stock Issued During Period Value Other
StockIssuedDuringPeriodValueOther
-49560 USD
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
20194 USD
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
10606 USD
CY2013Q4 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1
0.23
CY2013 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Lower Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeLowerRangeLimit
0.04
CY2013 us-gaap Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Upper Range Limit
ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeUpperRangeLimit
21.57
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
-14265547 USD
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
-11625145 USD
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
-10090028 USD
CY1997Q1 us-gaap Stockholders Equity
StockholdersEquity
USD
CY1997Q4 us-gaap Stockholders Equity
StockholdersEquity
877475 USD
CY1998Q4 us-gaap Stockholders Equity
StockholdersEquity
1580034 USD
CY1999Q4 us-gaap Stockholders Equity
StockholdersEquity
100548 USD
CY2000Q4 us-gaap Stockholders Equity
StockholdersEquity
5340631 USD
CY2001Q4 us-gaap Stockholders Equity
StockholdersEquity
2329208 USD
CY2002Q4 us-gaap Stockholders Equity
StockholdersEquity
-4374976 USD
CY2003Q4 us-gaap Stockholders Equity
StockholdersEquity
-3907307 USD
CY2004Q4 us-gaap Stockholders Equity
StockholdersEquity
-6967944 USD
CY2005Q4 us-gaap Stockholders Equity
StockholdersEquity
-9760207 USD
CY2006Q4 us-gaap Stockholders Equity
StockholdersEquity
2363005 USD
CY2007Q4 us-gaap Stockholders Equity
StockholdersEquity
-104296 USD
CY2008Q4 us-gaap Stockholders Equity
StockholdersEquity
-3345733 USD
CY2009Q4 us-gaap Stockholders Equity
StockholdersEquity
-5742027 USD
CY2010Q4 us-gaap Stockholders Equity
StockholdersEquity
-8065391 USD
CY2001 us-gaap Stockholders Equity Other
StockholdersEquityOther
-1206730 USD
CY2002 us-gaap Stockholders Equity Other
StockholdersEquityOther
-556047 USD
CY2003 us-gaap Stockholders Equity Other
StockholdersEquityOther
-343737 USD
CY2004 us-gaap Stockholders Equity Other
StockholdersEquityOther
-80218 USD
CY2005 us-gaap Stockholders Equity Other
StockholdersEquityOther
-92287 USD
CY2013 us-gaap Stock Issued1
StockIssued1
49647 USD
CY2012 us-gaap Stock Issued1
StockIssued1
247536 USD
CY2011 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
5141 USD
CY2013 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
456937 USD
CY2012 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
63128 USD
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
3025125 USD
CY2013 us-gaap Use Of Estimates
UseOfEstimates
<!--DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd" --><div> <div><!--StartFragment--> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> <strong>Use of Estimates</strong></p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in; font-size-adjust: none; font-stretch: normal"> &nbsp;</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; font-size-adjust: none; font-stretch: normal"> The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities. Actual results could differ from these estimates. Significant estimates in these financials are the valuation of options granted and the valuation of preferred shares issued as stock dividends.</p> <p style="FONT: 10pt Times New Roman, Times, Serif; MARGIN: 0pt 0px; TEXT-INDENT: 0.5in; font-size-adjust: none; font-stretch: normal"> <strong>&nbsp;</strong></p> <!--EndFragment--></div> </div>
CY2013Q4 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
171012 USD
CY2012Q4 us-gaap Warrants Not Settleable In Cash Fair Value Disclosure
WarrantsNotSettleableInCashFairValueDisclosure
38788 USD
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
236019072 shares
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
198228289 shares

Files In Submission

Name View Source Status
0001144204-14-019382-index-headers.html Edgar Link pending
0001144204-14-019382-index.html Edgar Link pending
0001144204-14-019382.txt Edgar Link pending
0001144204-14-019382-xbrl.zip Edgar Link pending
ctso-20131231.xml Edgar Link completed
ctso-20131231.xsd Edgar Link pending
ctso-20131231_cal.xml Edgar Link unprocessable
ctso-20131231_def.xml Edgar Link unprocessable
ctso-20131231_lab.xml Edgar Link unprocessable
ctso-20131231_pre.xml Edgar Link unprocessable
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
v372215_10k.htm Edgar Link pending
v372215_ex31-1.htm Edgar Link pending
v372215_ex31-2.htm Edgar Link pending
v372215_ex32-1.htm Edgar Link pending
v372215_ex32-2.htm Edgar Link pending